A Study to Assess Multidomain Endpoints of an ECG Patch

Active, not recruitingOBSERVATIONAL
Enrollment

41

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

December 26, 2025

Study Completion Date

December 26, 2025

Conditions
Acute Decompensated Heart Failure
Interventions
DEVICE

ECG Patch

Wearable ECG Patch designed to record and transmit physiological parameters to a mobile device or a data cloud. The device stores data locally in a memory cache designed for \>96 hours of continuous data. It continuously records a one-lead ECG and has a three-axis accelerometer. On-board algorithms use those data to compute heart rate, heart rate variability, RR-interval, respiratory rate, and an activity level indicator. The company also provides optional arrhythmia detection and reporting services, the results of which may be delivered to healthcare professionals.

Trial Locations (3)

CB2 0QQ

Research Site, Cambridge

LE3 9PQ

Research Site, Leicester

UB9 6JH

Research Site, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT06243029 - A Study to Assess Multidomain Endpoints of an ECG Patch | Biotech Hunter | Biotech Hunter